Apremilast, an oral phosphodiesterase 4 inhibitor, in patients with difficult-to-treat nail and scalp psoriasis: Results of 2 phase III randomized, controlled trials (ESTEEM 1 and ESTEEM 2)

Phoebe Rich, Melinda Gooderham, Hervé Bachelez, Joana Goncalves, Robert M. Day, Rongdean Chen, Jeffrey Crowley

Research output: Contribution to journal › Article › peer-review

119 Scopus citations

Fingerprint

Dive into the research topics of 'Apremilast, an oral phosphodiesterase 4 inhibitor, in patients with difficult-to-treat nail and scalp psoriasis: Results of 2 phase III randomized, controlled trials (ESTEEM 1 and ESTEEM 2)'. Together they form a unique fingerprint.

Medicine & Life Sciences